Azathioprine/mesalazine/tumour-necrosis-factor-inhibitors

Lack of efficacy and pulmonary tuberculosis: case report

    Reactions Weekly volume 1839, page58(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Guney M, et al. A patient with Crohn's disease during remission by biological agent treatment developed active pulmonary tuberculosis and determining the eating habits. European Journal of Gastroenterology and Hepatology 32: 541-542, No. 4, Apr 2020. Available from: URL: http://doi.org/10.1097/MEG.0000000000001602

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Azathioprine/mesalazine/tumour-necrosis-factor-inhibitors. Reactions Weekly 1839, 58 (2021). https://doi.org/10.1007/s40278-021-89896-3

    Download citation